Symptom Characteristics and Psychosomatic Profiles in Different Spectrum of Gastroesophageal Reflux Disease

키워드

참고문헌 (32)

1. Vakil N, "The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus", Am J Gastroenterol, 101, pp.1900~1920 (2006)
2. Fass R, "Gastroesophageal reflux disease: should we adopt a new conceptual framework?", Am J Gastroenterol, 97, pp.1901~1909 (2002)
3. Fullard M, "Systematic review: does gastro-oesophageal reflux disease progress?", Aliment Pharmacol Ther, 24, pp.33~45 (2006)
4. Frazzoni M, "Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease", Aliment Pharmacol Ther, 18, pp.1091~1098 (2003)
5. Kim N, "The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea", Aliment Pharmacol Ther, 27, pp.173~185 (2008)
6. Orr WC, "The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage", Am J Gastroenterol, 89, pp.509~512 (1994)
7. Wu JC, "Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis", Clin Gastroenterol Hepatol, 5, pp.690~695 (2007)
8. Lundell LR, "Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification", Gut, 45, pp.172~180 (1999)
9. Cho YK, "Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness", Scand J Gastroenterol, 45, pp.533~539 (2010)
10. Derogatis LR, "The SCL-90 and the MMPI: a step in the validation of a new self-report scale", Br J Psychiatry, 128, pp.280~289 (1976)
11. Kim JH, "The standardization study of Symptom Checklist-90-Revision in Korea III", Ment Health Res, 2, pp.278~311 (1984)
12. Streets CG, "Ambulatory 24-hour esophageal pH monitoring: why, when, and what to do", J Clin Gastroenterol, 37, pp.14~22 (2003)
13. Breumelhof R, "The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording", Am J Gastroenterol, 86, pp.160~164 (1991)
14. Lam HG, "What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data?", Dig Dis Sci, 39, pp.402~409 (1994)
15. Wiener GJ, "The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring", Am J Gastroenterol, 83, pp.358~361 (1988)
16. Hershcovici T, "Nonerosive reflux disease (NERD): an update", Neurogastroenterol Motil, 16, pp.8~21 (2010)
17. Fass R, "Therapeutic options for refractory gastroesophageal reflux disease", J Gastroenterol Hepatol, 27(Suppl 3), pp.3~7 (2012)
18. Lee WC, "Timely confirmation of gastroesophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations", Curr Med Res Opin, 24, pp.1317~1327 (2008)
19. Sifrim D, "Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors", Gut, 61, pp.1340~1354 (2012)
20. van der Velden AW, "Numans ME. Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial", Digestion, 81, pp.43~52 (2010)
21. Lee KJ, "Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group", Digestion, 79, pp.131~136 (2009)
22. Cicala M, "Intra-oesophageal distribution and perception of acid reflux in patients with nonerosive gastro-oesophageal reflux disease", Aliment Pharmacol Ther, 18, pp.605~613 (2003)
23. Schey R, "Comparison of the different characteristics of sensed reflux events among different heartburn groups", J Clin Gastroenterol, 43, pp.699~704 (2009)
24. Cho YS, "Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea", Am J Gastroenterol, 100, pp.747~753 (2005)
25. 이경수, "위식도역류질환 진단 및 임상양상에 있어서 내시경, 24시간 식도 산도검사, Bernstein 검사의 역할 및 증상과의 관계", 대한내과학회지, 70(2), pp.145~156 (2006), 대한내과학회
26. Wong WM, "Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study", Aliment Pharmacol Ther, 18, pp.595~604 (2003)
27. Corsetti M, "Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia", Am J Gastroenterol, 99, pp.1152~1159 (2004)
28. De Vries DR, "Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease", Scand J Gastroenterol, 42, pp.951~956 (2007)
29. Kennedy TM, "Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population", Gut, 43, pp.770~774 (1998)
30. Nastaskin I, "Studying the overlap between IBS and GERD: a systematic review of the literature", Dig Dis Sci, 51, pp.2113~2120 (2006)
31. Hu WH, "Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study", Aliment Pharmacol Ther, 16, pp.2081~2088 (2002)
32. 오정환, "Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease", Gut and Liver, 3(4), pp.259~265 (2009), 거트앤리버 발행위원회

관련 논문AI추천